Biomarkers: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Stub}} | {{Stub}} | ||
*{{pmid_text|37923875}} | *{{pmid_text|37923875}} | ||
* {{pmid text|34093670}} | * {{pmid text|34093670}} | ||
* | |||
== TOP 5 Biomarkers For Longevity == | |||
* https://www.youtube.com/shorts/IPv7zHrRY7Q | |||
{| class="wikitable" | {| class="wikitable" | ||
|+ | |+ | ||
! | !Biomarker | ||
! | ! | ||
|- | |- | ||
|Glucose Level HbA1c | |Glucose Level HbA1c | ||
| | | | ||
|- | |- | ||
|Inflammatory markers, especially cardiovascular like CRP should be low | |Inflammatory markers, especially cardiovascular like CRP should be low | ||
| | | | ||
|- | |- | ||
|Cholesterol markers including Lipoprotein(a) | |Cholesterol markers including Lipoprotein(a) | ||
| | | | ||
|- | |- | ||
|Hormone levels (testosterone) | |Hormone levels (testosterone) | ||
| | | | ||
|- | |- | ||
|Albumin | |Albumin | ||
| | | | ||
|} | |} | ||
Revision as of 20:53, 6 November 2023
This article is a stub. You can help by expanding it.
- 2023, Correction to: Blood biomarker profiles and exceptional longevity: comparison of centenarians and non‑centenarians in a 35‑year follow‑up of the Swedish AMORIS cohort [1]
- 2021, Ranking Biomarkers of Aging by Citation Profiling and Effort Scoring [2]
TOP 5 Biomarkers For Longevity
| Biomarker | |
|---|---|
| Glucose Level HbA1c | |
| Inflammatory markers, especially cardiovascular like CRP should be low | |
| Cholesterol markers including Lipoprotein(a) | |
| Hormone levels (testosterone) | |
| Albumin |
References
- ↑ Murata S et al.: Correction to: Blood biomarker profiles and exceptional longevity: comparison of centenarians and non‑centenarians in a 35‑year follow‑up of the Swedish AMORIS cohort. Geroscience 2023. (PMID 37923875) [PubMed] [DOI]
- ↑ Hartmann A et al.: Ranking Biomarkers of Aging by Citation Profiling and Effort Scoring. Front Genet 2021. (PMID 34093670) [PubMed] [DOI] [Full text] Aging affects most living organisms and includes the processes that reduce health and survival. The chronological and the biological age of individuals can differ remarkably, and there is a lack of reliable biomarkers to monitor the consequences of aging. In this review we give an overview of commonly mentioned and frequently used potential aging-related biomarkers. We were interested in biomarkers of aging in general and in biomarkers related to cellular senescence in particular. To answer the question whether a biological feature is relevant as a potential biomarker of aging or senescence in the scientific community we used the PICO strategy known from evidence-based medicine. We introduced two scoring systems, aimed at reflecting biomarker relevance and measurement effort, which can be used to support study designs in both clinical and research settings.